Innate Pharma S.A.Innate Pharma S.A.Innate Pharma S.A.

Innate Pharma S.A.

No trades
See on Supercharts

IPHA fundamentals

An in-depth look to Innate Pharma S.A. operating, investing, and financing activities

IPHA free cash flow for H1 24 is 2.98 M USD. For 2023, IPHA free cash flow was -35.58 M USD and operating cash flow was -35.2 M USD.

‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM
Free cash flowYoY growth